[go: up one dir, main page]

DK1279665T3 - Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelser - Google Patents

Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelser

Info

Publication number
DK1279665T3
DK1279665T3 DK02016262T DK02016262T DK1279665T3 DK 1279665 T3 DK1279665 T3 DK 1279665T3 DK 02016262 T DK02016262 T DK 02016262T DK 02016262 T DK02016262 T DK 02016262T DK 1279665 T3 DK1279665 T3 DK 1279665T3
Authority
DK
Denmark
Prior art keywords
perindopril
dioxo
salts
preparation
analogous compounds
Prior art date
Application number
DK02016262T
Other languages
English (en)
Inventor
Pau Cid
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8183486&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1279665(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK1279665T3 publication Critical patent/DK1279665T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44Two oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
DK02016262T 2001-07-24 2002-07-23 Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelser DK1279665T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01500197 2001-07-24
EP02016262A EP1279665B1 (en) 2001-07-24 2002-07-23 A process for the preparation of perindopril, its analogous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds

Publications (1)

Publication Number Publication Date
DK1279665T3 true DK1279665T3 (da) 2008-06-23

Family

ID=8183486

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02016262T DK1279665T3 (da) 2001-07-24 2002-07-23 Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelser

Country Status (23)

Country Link
US (1) US20040248814A1 (da)
EP (1) EP1279665B1 (da)
JP (1) JP4083118B2 (da)
KR (1) KR100694528B1 (da)
CN (1) CN100503568C (da)
AR (1) AR036187A1 (da)
AT (1) ATE386717T1 (da)
AU (1) AU2002328954B2 (da)
BR (1) BR0211422A (da)
CY (1) CY1107403T1 (da)
DE (1) DE60225092T2 (da)
DK (1) DK1279665T3 (da)
EA (1) EA007000B1 (da)
ES (1) ES2300402T3 (da)
HU (1) HUP0202414A3 (da)
MX (1) MXPA04000649A (da)
NO (1) NO20040278L (da)
NZ (1) NZ530578A (da)
PL (1) PL355161A1 (da)
PT (1) PT1279665E (da)
SI (1) SI1279665T1 (da)
WO (1) WO2003010142A2 (da)
ZA (1) ZA200400323B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1333026B1 (en) * 2002-01-30 2007-06-27 Les Laboratoires Servier Process for the preparation of high purity perindopril and intermediates useful in the synthesis
CA2517205C (en) 2003-02-28 2010-08-24 Lupin Limited Process for preparation of perindopril and salts thereof
JP4733023B2 (ja) 2003-04-16 2011-07-27 ブリストル−マイヤーズ スクイブ カンパニー C型肝炎ウイルスの大環状イソキノリンペプチド阻害剤
SI21506A (sl) * 2003-05-08 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo perindoprila
SI21507A (sl) * 2003-05-16 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo spojin z ace inhibitornim delovanjem
AU2003263584A1 (en) * 2003-08-21 2005-03-10 Hetero Drugs Limited Process for pure perindopril tert-butylamine salt
DK1675827T3 (da) * 2003-10-21 2010-04-19 Servier Lab Ny fremgangsmåde til fremstilling af krystallint perindopril erbumin
SI21703A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
ES2255872B1 (es) * 2004-12-31 2007-08-16 Quimica Sintetica, S.A. Procedimiento para la preparacion de perindopril erbumina.
US7291745B2 (en) 2005-03-21 2007-11-06 Glenmark Pharmaceuticals Limited Process for the preparation of perindopril
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
WO2006137082A1 (en) * 2005-06-23 2006-12-28 Ramesh Babu Potluri Process for industrially viable preparation of perindopril erbumine
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
UA98767C2 (uk) * 2006-05-12 2012-06-25 Егіш Дьйодьсердьяр Нільваношан Мюкьодо Ресвеньтаршашаг Фармацевтичні проміжні сполуки в синтезі інгібіторів ацетилхолінестерази (асе)
JP2008019214A (ja) * 2006-07-13 2008-01-31 Shiono Chemical Co Ltd ペリンドプリルまたはその誘導体の製造方法
EP2150538B1 (en) 2007-06-06 2012-03-28 DSM Sinochem Pharmaceuticals Netherlands B.V. Novel 5-substituted hydantoins
FR2985512B1 (fr) 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
CN111116709B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种培哚普利制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2487829A2 (fr) * 1979-12-07 1982-02-05 Science Union & Cie Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
US4508729A (en) * 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
ZA817261B (en) * 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
ATE20469T1 (de) * 1980-10-23 1986-07-15 Schering Corp Carboxyalkyl-dipeptide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
US4558038A (en) * 1981-03-30 1985-12-10 Usv Pharmaceutical Corp. N-Substituted-amindo-amino acids
US4496542A (en) * 1981-03-30 1985-01-29 Usv Pharmaceutical Corporation N-substituted-amido-amino acids
US4686295A (en) * 1982-03-10 1987-08-11 Usv Pharmaceutical Corporation N-carboxy anhydride intermediates
US4885293A (en) * 1984-09-24 1989-12-05 Schering Corporation Antiglaucoma agents
JPS6248696A (ja) * 1985-08-27 1987-03-03 Kanegafuchi Chem Ind Co Ltd N−〔1(s)−エトキシカルボニル−3−フエニルプロピル〕−l−アラニル−l−プロリンの製造法
ES2004804A6 (es) * 1987-08-13 1989-02-01 Pharma Investi S A Un procedimiento para preparar derivados de carboxialquildipeptidos
FR2620703B1 (fr) * 1987-09-17 1991-10-04 Adir Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides
FR2620699B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et de leurs esters. application a la synthese de carboxyalkyl dipeptides
FR2620700B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et leurs esters. application a la synthese de carboxyalkyl dipeptides
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
US5258525A (en) * 1991-03-27 1993-11-02 Mcneilab, Inc. Processes for preparing [2S-(2α,3aβ,7aβ)]octahydro-1H-indole-2-carboxylic acid and esters
SI9200213A (en) * 1992-09-16 1994-03-31 Krka Process for preparing alkyl-l-alanil-l-proline derivates
IN184759B (da) 1997-07-22 2000-09-23 Kaneka Corp
SE0000382D0 (sv) * 2000-02-07 2000-02-07 Astrazeneca Ab New process

Also Published As

Publication number Publication date
BR0211422A (pt) 2004-08-17
EA200400129A1 (ru) 2004-08-26
HUP0202414A2 (hu) 2003-02-28
DE60225092T2 (de) 2009-02-19
CN100503568C (zh) 2009-06-24
DE60225092D1 (de) 2008-04-03
HK1067129A1 (en) 2005-04-01
EP1279665A3 (en) 2003-03-12
HU0202414D0 (da) 2002-09-28
NZ530578A (en) 2007-02-23
WO2003010142A2 (en) 2003-02-06
EA007000B1 (ru) 2006-06-30
ZA200400323B (en) 2005-03-30
PL355161A1 (en) 2003-01-13
CN1529694A (zh) 2004-09-15
ATE386717T1 (de) 2008-03-15
HUP0202414A3 (en) 2003-05-28
MXPA04000649A (es) 2004-10-27
KR20040029378A (ko) 2004-04-06
PT1279665E (pt) 2008-03-28
EP1279665A2 (en) 2003-01-29
ES2300402T3 (es) 2008-06-16
SI1279665T1 (sl) 2008-06-30
AR036187A1 (es) 2004-08-18
EP1279665B1 (en) 2008-02-20
KR100694528B1 (ko) 2007-03-13
NO20040278L (no) 2004-01-21
WO2003010142A3 (en) 2003-08-28
CY1107403T1 (el) 2012-12-19
AU2002328954B2 (en) 2007-10-04
US20040248814A1 (en) 2004-12-09
JP4083118B2 (ja) 2008-04-30
JP2005501829A (ja) 2005-01-20

Similar Documents

Publication Publication Date Title
DK1279665T3 (da) Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelser
DK1312406T3 (da) Fremgangsmåde til rensning af syntesegas
DK1163207T3 (da) Forbedret fremgangsmåde til fremstillingen af ikke-hygroskopiske salte af L(-)-carnitin
DK1268424T3 (da) Fremgangsmåde til syntese af perindopril og dets farmaceutisk acceptable salte
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
IS7755A (is) Aðferð við framleiðslu á (S,S)-cis-2-benshýdríl-3-bensýlamínókínuklídín
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1383733T3 (da) Fremgangsmåde til fremstilling af 1,3-substituerede indener og aryl-sammenföjede azapolycykliske forbindelser
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
DK1385826T3 (da) Fremgangsmåde til fremstilling af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azapin-5-carboxamid
DK1392318T3 (da) 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
DK1407037T3 (da) Fremgangsmåde til fremstilling af tagatose
NO20033433D0 (no) Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol
DK1110922T3 (da) Fremgangsmåde til termisk behandling af melformede råmaterialer
DK1958938T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
NO331195B1 (no) Fremgangsmate for fremstilling av halogen-substituerte monosulfider og deres hydroksymonosulfid-evkivalenter som mellomprodukter.
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
DK1075473T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer
DK1395587T3 (da) Fremgangsmåde til fremstilling af imipenem
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1503995T3 (da) Fremgangsmåde til fremstilling af substituerede phenylsulfonylurinstoffer
DK1519936T3 (da) Fremgangsmåde til fremstilling af nevirapin
EP1565448A4 (en) PROCESS FOR THE PREPARATION OF 10H-DIBENZOçB, F] ç1,4] THIAZEPIN-11-ON
DK0981950T3 (da) Fremgangsm,åde til formering af phyllocactus